Leadership Team 2015-2016
Susan Qu, Ph.D. MBA
External Manufacturing Integrated Risk Manager, Genzyme Corporation, a division of Sanofi, Framingham, MA
Chairman of the Board
Shiwen Lin, Ph.D.
Director, Process & Analytical Technologies, Agenus, Inc. Lexington, MA
Eric Shi, Ph.D.
Investigator, GSK, Waltham, MA
Vice President of Communications
Qinglin Che, Ph.D.
Senior Scientist, Synta Pharmaceuticals, Inc., Lexington, MA
Vice President of Finance
Zhendong Zhu, Ph.D.
Principal Investigator, Celgene Avilomics Research, Bedford, MA
General Manager of Public Relations
Qingqing Cao, Ph.D.
Sr. Engineer, Becton Dickinson (BD)-Bioscience, Bedford, MA
General Manager of Operations
Ellen Fan, MSc.
Sr. Scientist, Arsenal Medical Inc. Watertown, MA
Liping Zhou, Ph.D.
Senior Scientist, Ipsen Biosciences., Cambridge, MA
Attorney at Law, Lynch, DeSimone & Nylen, LLP, Boston, MA
Executive Committee Members
Yin Chen, Ph.D.
Director of Business Development at Accelagen
Shujia Daniel Dai, Ph.D.
Principal Reserach Investigator, Sanofi-Aventis
Kevin Fang, Ph.D.
Sr. Director of Medicinal Chemistry, Sunovion Pharmaceuticals Inc., Marlborough, MA
Henry Gu, J.D.
Intellectual Property Counsel, Agios Pharmaceuticals, Cambridge, MA
Jianfeng Jeff Hang, Ph.D.
Regulatory Affairs and Quality System Consultant, Makromed, Inc., Salem, NH
Jinbo Lee, Ph.D.
Co-founder and CSO, Scilligence Corporation, Burlington, MA
Jo Lee, M.Ec.
Founder, Somebusiness, Inc.
Hao Howard Li, Ph.D., MBA
Cambridge Site Head, Novartis Knowledge Center, Novartis, Cambridge, MA
Jing Jeannie Li, Ph.D.
Senior Scientist, Pfizer, Cambridge, MA
Carrie Liu, Ph.D.
Associate Director of Analytical Chemistry, Concert Pharmaceuticals, Lexington, MA
Sue Ma, M.D.
Scientist II, Novartis Institute of BioMedical Research, Cambridge, MA
Jian Shao, MBA
Venture Partner at Azimuth Ventures
Ze Tian, Ph.D.
Staff Scientist, Curis, Inc., Lexington, MA
Yueming Wang, MBA
Board Member and CEO of Zhonguan Pharmaceutical Co. Ltd., Beijing, China
Zhigang Wang, Ph.D.
Sr. Principal Scientist, Celgene Avilomics Research, Bedford, MA
Li Xing, Ph. D.
Senior Principal Scientist, Pfizer, Cambridge, MA
Wendy Yang, MBA
Sr. Project Manager, Genzyme Corporation, a division of Sanofi, Waltham, MA
Bo Ying, Ph.D.
Senior Scientist, Onkaido Therapeutics, a Moderna Venture
Jingzhong Jeff Zhang, Ph.D.
Senior Scientist, Medica Corp
Wei Zhang, Ph.D.
Staff Scientist, Siemens Healthcare Diagnostics, Norwood , MA
Youxin Zhang, Ph.D.
Managing Consultant, Navigant Consulting, Boston, MA
Xiaoyong Zhao, Ph.D.
Senior Scientist, Momenta
Board of Directors
Zhihong Chen, Ph.D.
Past President (2011-2012)
Chaoyang Dai, Ph.D.; Past president (2010-2011)
President, Boston Biosolutions
Jun Han, Ph. D.; Founding President
CEO, SOTA International LLC, Boston, MA
Lixin Shen, Ph. D.
President and CEO, Wuxi Howfond Biopharma Co., Ltd., Jiangsu, China
Zhao-Kui Wan, Ph. D.; Past-President (2009-2010)
Head of Chemistry, Jassen Pharmaceutical Companies of Johnson & Johnson, Shanghai, China
Yihan Wang, Ph. D.
President, Shenzhen TargetRx, Inc., Shenzhen, China
Erxi Wu, Ph. D.
Assistant Prof., North Dakota State University, Fargo, ND
Junjun Wu, Ph. D.; Past President (2007-2009)
CEO，WuXi AllNature Biotech LLC, Jiangsu, China
Xiang Yang Yu, Ph. D.; Past president (2013-2014)
Program Manager, Accellient Partners LLC, Waltham, MA
Zhiyong Yang, Ph.D.; Past president (2014-2015)
Senior Principal Scientist, Pfizer, Cambridge, MA
Philip Zhang, Ph. D., J. D.; Past President (2012-2013)
Co-Founder and Chairman, Milstein Zhang & Wu LLC, Newton, MA
Youssef Bennani, Ph. D.
Site Head, Vertex Pharmaceuticals Inc.-Canada
Tim Clackson, Ph. D.
President of Research and Development and Chief Scientific Officer, Ariad Pharmaceuticals Inc., Cambridge, MA
Yuan-Hua Ding, Ph. D.
Senior Director & Head of External R&D Innovation - Asia, Pfizer
Pierre Dodion, M. D., MBA
Sr. VP, Corporate Development, Ariad Pharmaceuticals Inc., Cambridge, MA
Chen Li, Ph. D.
Chief Executive Officer, Hua Medicine, Inc., Shanghai, China
Luke Li, Ph. D.
Exec Director, Head of Global Biotherapeutic Technologies, Bio-Innovation, Pfizer
Shi Li, Ph. D.
CEO, Zerun Biotechnology, Shanghai, CHINA
Yuanli Liu, Ph. D.
Director of China Initiative, Sr. Lecturer on International Health, Dept. of Global Health and Population, Harvard School of Public Health
Dawei Ma , Ph. D.
Professor, Shanghai Institute of Organic Chemistry, Shanghai, China
Tarek Mansour, Ph. D.
EVP of Research & Development, Xenon Pharmaceuticals Inc., Vancouver, Canada
Chairman, Sino Biopharmaceutical Ltd., Beijing, China
John Piwinski, Ph. D.
Principal, JJPiwinski Pharma Consulting, LLC, New York, NY
Steve Projan, Ph. D.
Sr. V.P. R&D, Innovative Medicines Head of Infectious Diseases & Vaccines, MedImmune, Gaithersburg, MD
Tomi Sawyer, Ph. D.
Chief Scientific Officer and Senior Vice-President, Aileron Therapeutics, Cambridge, MA
Liming Shao, Ph. D.
Professor, Fudan University, Shanghai, China
Suvit Thaisrivongs, Ph. D.
Vice President, Pfizer, Inc., Cambridge. MA
Roger Tung, Ph. D.
CEO and President, Concert Pharmaceuticals, Lexington, MA
Yibin Xiang, Ph. D.
CSO, Sanhome Pharma
Gangfeng Xu, Ph. D.
Divisional Vice President, Corporate Licensing & Acquisitions at Abbott Laboratories
Steve Yang, Ph. D.
Executive VP & COO, Wuxi Apptec
Howard Yuwen, Ph. D.
Co-founder & VP Corporate Development & Regulatory Affairs, Genesun Pharmaceuticals
Zhaohui Sunny Zhou, Ph. D.
Associate Professor, Department of Chemistry and Chemical Biology and Faculty Fellow, Barnett Institute of Chemical and BiologicalAnalysis, Northeastern University
CABA Thank the dedicated service from the 8 retired EC members: Lan Cao, Fred Hu, Shengfang Jin, Ji Shi, Shallwei Sun, Yikai Wang, YongZhong Wang and Weiyi Wendy Zhang